Kynamro
Country: European Union
Language: Maltese
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
22-03-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
mipomersen sodium
Available from:
Genzyme Europe BV
ATC code:
C10AX11
INN (International Name):
mipomersen sodium
Therapeutic group:
Sistema kardjovaskulari
Therapeutic area:
Iperkolesterolemija
Therapeutic indications:
it-trattament tal-kolesterol u l-iperkolesterolimja,.
Authorization status:
Miċħuda
